You are here

  • Home
  • Archive
  • Volume 76, Issue Suppl 2
  • AB1143 The impact of anti-cyclic citrullinated peptide seropositivity on erosion prevalence among patients with rheumatoid arthritis of varying disease duration

Citation Tools

Article menu

Download PDFPDF

Abstracts Accepted for Publication
Epidemiology, risk factors for disease or disease progression
AB1143 The impact of anti-cyclic citrullinated peptide seropositivity on erosion prevalence among patients with rheumatoid arthritis of varying disease duration
Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Harrold L, Price K, Litman H, et al
AB1143 The impact of anti-cyclic citrullinated peptide seropositivity on erosion prevalence among patients with rheumatoid arthritis of varying disease duration
Annals of the Rheumatic Diseases 2017;76:1455.